Soligenix Inc (SNGX): Next-Year EPS Estimate 37.50%
As of 2026-06-11, Soligenix Inc (SNGX) has a next-year EPS growth estimate of 37.50%.
On 2026-05-04, analyst consensus for SNGX's next-year EPS growth shifted from 60.28% to 37.50% — a negative change of 22.78 percentage points. The revised estimate has been sustained across 29 subsequent trading sessions. Current-year growth is projected at 81.31%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 37.50%
- EPS growth this year
- 81.31%
- EPS next quarter (est)
- -$0.15
- Last price
- $0.43
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 37.50% | 81.31% | -$0.15 | $0.43 |
| 2026-06-10 | 37.50% | 81.31% | -$0.15 | $0.46 |
| 2026-06-09 | 37.50% | 81.31% | -$0.15 | $0.43 |
| 2026-06-08 | 37.50% | 81.31% | -$0.15 | $0.42 |
| 2026-06-07 | 37.50% | 81.31% | -$0.15 | $0.44 |
| 2026-06-04 | 37.50% | 81.31% | -$0.15 | $0.48 |
| 2026-06-03 | 37.50% | 81.31% | -$0.15 | $0.48 |
| 2026-06-02 | 37.50% | 81.31% | -$0.15 | $0.75 |
| 2026-06-01 | 37.50% | 81.31% | -$0.15 | $0.83 |
| 2026-05-31 | 37.50% | 81.31% | -$0.15 | $0.91 |
| 2026-05-28 | 37.50% | 81.31% | -$0.15 | $0.97 |
| 2026-05-27 | 37.50% | 81.31% | -$0.15 | $0.87 |
| 2026-05-26 | 37.50% | 81.31% | -$0.15 | $0.51 |
| 2026-05-25 | 37.50% | 81.31% | -$0.15 | $0.39 |
| 2026-05-24 | 37.50% | 81.31% | -$0.15 | $0.39 |
| 2026-05-21 | 37.50% | 81.31% | -$0.15 | $0.39 |
| 2026-05-20 | 37.50% | 81.31% | -$0.15 | $0.39 |
| 2026-05-19 | 37.50% | 81.31% | -$0.15 | $0.38 |
| 2026-05-18 | 37.50% | 81.31% | -$0.15 | $0.41 |
| 2026-05-17 | 37.50% | 81.31% | -$0.15 | $0.36 |
| 2026-05-14 | 37.50% | 81.31% | -$0.20 | $0.41 |
| 2026-05-13 | 37.50% | 81.31% | -$0.20 | $0.36 |
| 2026-05-12 | 37.50% | 81.31% | -$0.20 | $0.31 |
| 2026-05-11 | 37.50% | 81.31% | -$0.20 | $0.28 |
| 2026-05-10 | 37.50% | 81.31% | -$0.20 | $0.29 |
| 2026-05-07 | 37.50% | 81.31% | -$0.27 | $0.31 |
| 2026-05-06 | 37.50% | 81.31% | -$0.27 | $0.33 |
| 2026-05-05 | 37.50% | 81.31% | -$0.27 | $0.32 |
| 2026-05-04 | 37.50% | 81.31% | -$0.27 | $0.34 |
| 2026-04-01 | 60.28% | N/A | N/A | $1.15 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Soligenix Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Soligenix Inc (SNGX) has a next-year EPS growth estimate of 37.50%, based on analyst consensus.
When was the latest EPS estimate revision for SNGX?▾
The most recent revision occurred on 2026-05-04, when analysts adjusted the next-year EPS growth estimate from 60.28% to 37.50%.
What sector and industry does Soligenix Inc belong to?▾
Soligenix Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. SNGX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Soligenix Inc (SNGX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports